Where does Greg Timblin work?

Greg Timblin is Executive in Residence, Therapeutics at GENERAL INCEPTION.

Where did Greg Timblin go to school?

Greg Timblin studied at University of California, Berkeley (Doctor of Philosophy (PhD), Molecular & Cell Biology (immunology emphasis)); Nebraska Wesleyan University (Bachelor of Science x2, B.S. Biology and B.S. Chemistry).

Greg Timblin

Investor

Executive in Residence, Therapeutics at GENERAL INCEPTION

Berkeley, California, United States

About

Greg Timblin is CEO and co-founder of Inapill, a company developing therapeutics that target immune cell metabolism to treat age-related chronic inflammatory and autoimmune diseases. He holds B.S. degrees in Chemistry and Biology from Nebraska Wesleyan University and a Ph.D. in Molecular and Cell Biology from UC Berkeley, and completed postdoctoral research at UC Berkeley and UCSF studying proinflammatory gene expression and metabolic-epigenetic pathways in the immune system. He co-founded Inapill with Josh Farahzad; the company is supported by venture studio General Inception and operates out of Bakar Bio Labs on the UC Berkeley campus.

Contact· self-published, not guessed

g•••@generalinception.comreveal

Experience

InapillCEO & co-foundercurrent2023 — presentBerkeley, California, United States
University of California, San FranciscoADA Postdoctoral Fellow at UCSF2021 — 2023Laboratory of Dr. Valerie Weaver
UC BerkeleyADA Postdoctoral Fellow2017 — 2021Kaoru Saijo Lab
UC BerkeleyPhD Candidate (Molecular and Cell Biology Graduate Program)2008 — 2014
UC BerkeleyUndergraduate Researcher (Amgen Scholars Program)2007
University of Colorado BoulderUndergraduate Researcher2005 — 2006

Skills & more

Molecular Biology5Molecular ImmunologyImmunology4Biochemistry4Cancer Cell BiologyLeukemiaMammalian Cell Culture1Flow Cytometry4Chromatin ImmunoprecipitationCell Biology8Fluorescence Microscopy2Cell Culture3

+9 more

PCRProtein ExpressionProtein PurificationMolecular CloningqPCRAssay DevelopmentDNAWestern BlottingPolymerase Chain Reaction (PCR)

From Greg's professional profile.

Colleagues at GENERAL INCEPTION

Adam Weischhaus

Executives in Residence at GENERAL INCEPTION

Adam Wieschhaus

Investor at GENERAL INCEPTION

Alan Dance

Executives in Residence at GENERAL INCEPTION

Arunan Skandarajah

Executives in Residence at GENERAL INCEPTION

Autumn Lee

Chief of Staff at GENERAL INCEPTION

Brad Crutchfield

Executives in Residence at GENERAL INCEPTION

Brad Nelson

Life Science Tools & Dx at GENERAL INCEPTION

Byron Hewett

Executives in Residence at GENERAL INCEPTION

Frequently asked questions

Who is Greg Timblin?: Greg Timblin is CEO and co-founder of Inapill, a company developing therapeutics that target immune cell metabolism to treat age-related chronic inflammatory and autoimmune diseases. He holds B.S. degrees in Chemistry and Biology from Nebraska Wesleyan University and a Ph.D. in Molecular and Cell Biology from UC Berkeley, and completed postdoctoral research at UC Berkeley and UCSF studying proinflammatory gene expression and metabolic-epigenetic pathways in the immune system. He co-founded Inapill with Josh Farahzad; the company is supported by venture studio General Inception and operates out of Bakar Bio Labs on the UC Berkeley campus.
Where does Greg Timblin work?: Greg Timblin is Executive in Residence, Therapeutics at GENERAL INCEPTION.
Where did Greg Timblin go to school?: Greg Timblin studied at University of California, Berkeley (Doctor of Philosophy (PhD), Molecular & Cell Biology (immunology emphasis)); Nebraska Wesleyan University (Bachelor of Science x2, B.S. Biology and B.S. Chemistry).

Same school

Also attended University of California, Berkeley1,455

Byron DeeterPartner at Bessemer Venture Partners Steve WozniakCo-founder of Apple Tony XuCo-founder & CEO of DoorDash Aravind SrinivasCo-founder & CEO of Perplexity AI Ali GhodsiCo-founder & CEO of Databricks Ryan PetersenFounder & CEO of Flexport

+ 1,449 more

Also attended Nebraska Wesleyan University4

Lee NewcomerAdvisor at Oncology Ventures Logan SaccoUnderwriter at Breakout Capital Phillip AbbeySenior Associate at InvestBev Will WeberFounder at Humoniq

Shared employers

Also worked at University of California, San Francisco84

Logan HilleLife Sciences Analyst at CincyTech Paul JennyBoard Chair at CincyTech David KaufmanInvestor at Third Rock Ventures Francisco GimenezInvestment Team at 8VC Hani GoodarziFounder, Tahoe Therapeutics at Amplify Partners Charles White, Ph.D.Principal at Illumina Ventures

+ 78 more

Also worked at UC Berkeley311

Ali GhodsiCo-founder & CEO of Databricks Raquel UrtasunFounder & CEO of Waabi Arhaan A.Deeptech Fellow at Clear Ventures Paul JennyBoard Chair at CincyTech Andrea van ElsasInvestor at Third Rock Ventures Michael PerezDeputy General Counsel at Mucker Capital

+ 305 more

Also worked at University of Colorado Boulder48

Sydney EberhardtInvestor at True Ventures Samuel ArbesmanVenture Partner at Lux Capital Jaclyn Freeman HesterGeneral Partner at Foundry Todd WallachEntrepreneur-In-Residence at The Innovation Space Kyle DuffyOperating Partner at Gradient who helps early-stage founders go from 0 to 1 Dor SelaGrowth Strategist at Joyance Partners

+ 42 more